Recent studies demonstrated that human EGF-like receptor 2 (HER-2/Neu), structurally related to EGFR, is overexpressed in one-third of B-cell acute lymphoblastic leukemia (B-ALL) patients, who display resistance to conventional chemotherapies [13]. The gene discussed is ERBB2; the disease is precursor B-cell acute lymphoblastic leukemia.